Free Newsletter
U.S. lawmakers aim for new stem cell law
The latest revelations on new sources of versatile adult stem cells like that found in amniotic fluid are likely to become a major bone of contention among conservative lawmakers lining up against a new Democratic initiative aimed at changing the restrictive policies of the federal government when it comes to underwriting stem cell research. The Dems want to make federal funding available to groups obtaining embryonic stem cells from fertility clinics that otherwise would have to dispose of them. A number of Republican lawmakers have already joined with the Democrats to pass similar legislation that ran head-on into a presidential veto. The key question for outside observers is if the proponents of the bill now have the votes to override a presidential veto, which is likely in the event any such legislation hits the president's desk.
- here's the AP report on the new legislation
ALSO: In the U.K., meanwhile, researchers are advocating against any restrictions on the creation of animal/human hybrid embryos. Scientists have been using animal cells for their work with human DNA. Report
Related Articles:
Poll shows support for Democrats' stem cell agenda. Report
Bush vetoes stem cell bill, override fails. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: